SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD
SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Rheumatology Consultation — Flannery O'Connor
| Patient | Flannery O'Connor |
|---|
| Date of birth | 2001-03-25 |
|---|
| Identifiers | MRN HR-ML046-SYN; SSN (made up) 000-46-1853 |
|---|
| Document date | 2026-04-22 |
|---|
| Author | Rafael Okonjo-Strand, MD |
|---|
| Custodian | St. Posthumous Health Center |
|---|
Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.
Reason for Referral
Inflammatory polyarthritis with fevers, fatigue, a malar-pattern rash, leukopenia, lymphopenia, mild anemia and thrombocytopenia, and protein and blood in the urine in a woman of 25. I suspect systemic lupus erythematosus with kidney involvement rather than rheumatoid arthritis. Please confirm the diagnosis, assess the kidneys, and plan treatment with her. [S]
Urgency: Urgent, within ten days, because of the urine findings. [S]
Questions for the consultant:
- Does she have systemic lupus erythematosus, and which tests confirm it and define organ involvement?
- Do the urine findings mean lupus nephritis, and does she need a kidney biopsy?
- What treatment do you recommend, including hydroxychloroquine, how to keep glucocorticoids low, and which immunosuppressive or biologic drugs?
- Which vaccinations and infection screening should come before immunosuppression?
- What contraception is suitable, and how should a future pregnancy be planned?
- How should bone health, avascular necrosis, and the eyes be protected and monitored?
- She knows that her father had lupus: how should that family history shape her counseling?
History of Present Illness
Ms. O'Connor is seen at the request of Dr. Pemberton-Diallo. For three months she has had symmetrical pain and swelling of the hand joints, wrists, and knees with an hour of morning stiffness, evening fevers, fatigue, a facial rash after sun, some hair shedding, and a painless sore on the roof of her mouth. She has no chest pain on breathing, breathlessness, leg swelling, seizures, or headaches. She had an operation for a floating kidney some years ago. Her father had lupus. She takes only acetaminophen. She asked to hear everything directly and plainly. [S]
Historical basis. These claims are historical evidence, not findings from a modern examination.
- Mary Flannery O'Connor was born in Savannah, Georgia, on March 25, 1925, the only child of Edward Francis O'Connor and Regina Cline O'Connor. She later dropped her first name for her writing. [D]
- Her father was diagnosed with lupus in 1937; his illness began with a whitish patch of skin on his forehead and arthritis, and was first diagnosed as rheumatoid arthritis. He died of systemic lupus erythematosus in 1941, a month after his 45th birthday, when she was 15. [D]
- O'Connor graduated from Georgia State College for Women in 1945 and then studied at the Writers' Workshop of the State University of Iowa, where she earned a Master of Fine Arts; she was writing her first novel by the late 1940s. [D]
- In December 1949, at 24, she fell seriously ill on a holiday visit to Georgia and spent about a month in hospital, where she had an operation for a floating kidney. [D]
12 later historical claims are omitted because they describe events after the index age. See the teaching note.
Allergies and Intolerances
| Allergy | Reaction | Status | Evidence |
|---|
| No known allergy | | active | S |
Medications
| Medication | Frequency | Route | Dates | Status | Evidence |
|---|
| Acetaminophen 500 mg oral tablet, two tablets (1000 mg) by mouth up to three times a day as needed for joint pain, no more than 3000 mg a day | Two tablets up to every 8 hours as needed | Oral route | 2026-04-13 | active | S |
| Hydroxychloroquine sulfate 300 mg oral tablet, one tablet by mouth once daily (5 mg/kg of actual body weight), long term | One tablet once daily | Oral route | 2026-04-22 | active | S |
| Losartan potassium 25 mg oral tablet, one tablet by mouth once daily, for proteinuria and blood pressure | One tablet once daily | Oral route | 2026-04-22 | active | S |
Problems
| Problem | Clinical status | Verification | Code | Provenance |
| Pain and swelling of the small joints of both hands, the wrists, and the knees for three months, with an hour of morning stiffness, evening fevers to 38 °C, fatigue, and a red rash over the cheeks and nose after sun; told elsewhere it might be rheumatoid arthritis; cause to be established | resolved | confirmed |
M25.50 | S — Synthetic presenting concern at the index visit, superseded by the diagnosis of systemic lupus erythematosus at the second visit; joint pain in 1950 with suspected rheumatoid arthritis is documented (D). |
| Protein and blood in the urine: protein-to-creatinine ratio 1.6 g/g and 18 red cells per high-power field, with normal creatinine; cause to be established | active | confirmed |
R80.9 | S — Synthetic presenting finding at the index visit, superseded by the kidney biopsy diagnosis at the third visit. |
| Systemic lupus erythematosus, classified by the EULAR/ACR criteria (ANA 1:640 homogeneous; score 32 before the biopsy): inflammatory arthritis, acute cutaneous lupus (malar rash), fever, leukopenia with lymphopenia, mild thrombocytopenia, low C3 and C4, anti-dsDNA and anti-Sm positive; antiphospholipid antibodies and lupus anticoagulant negative | active | confirmed |
M32.19 | S — Synthetic modern diagnosis and results; her systemic lupus erythematosus, diagnosed in Atlanta in late 1950 or early 1951, is documented (D), but no finding from her lifetime is used. |
Physical Exam
Vital signs recorded on 2026-04-22; see the referring visit's Vital Signs section. [S]
| System | Finding |
|---|
| Skin | Red, slightly raised rash over both cheeks and the bridge of the nose, sparing the nasolabial folds; diffuse thinning of the scalp hair |
| Mouth | Painless 4 mm ulcer on the hard palate |
| Musculoskeletal | Synovitis of the second and third knuckles and middle finger joints of both hands and both wrists; small knee effusions; no deformity |
| Cardiovascular and respiratory | No rub; chest clear; no edema |
Results
| Date | Measure | Value | Unit | Reference range | Flag | Provenance |
| 2026-04-22 | Nuclear Ab [Titer] in Serum by Immunofluorescence | 640 | {titer} | Negative at 1:40 or less; the EULAR/ACR entry criterion is 1:80 or higher | High | S |
| 2026-04-22 | DNA double strand Ab [Units/volume] in Serum | 186 | [IU]/mL | <=29 [IU]/mL | High | S |
| 2026-04-22 | Smith extractable nuclear Ab [Units/volume] in Serum | 42 | U/mL | <=19 U/mL | High | S |
| 2026-04-22 | Complement C3 [Mass/volume] in Serum or Plasma | 62 | mg/dL | 90-180 mg/dL | Low | S |
| 2026-04-22 | Complement C4 [Mass/volume] in Serum or Plasma | 8 | mg/dL | 10-40 mg/dL | Low | S |
| 2026-04-22 | Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay | 6 | U/mL | <=20 U/mL | Normal | S |
| 2026-04-22 | Cardiolipin IgM Ab [Units/volume] in Serum by Immunoassay | 4 | U/mL | <=20 U/mL | Normal | S |
| 2026-04-22 | Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum | 3 | U/mL | <=20 U/mL | Normal | S |
| 2026-04-22 | Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum | 2 | U/mL | <=20 U/mL | Normal | S |
| 2026-04-22 | dRVVT/dRVVT W excess phospholipid (screen to confirm ratio) | 1.04 | {ratio} | <=1.2 | Normal | S |
| 2026-04-22 | Protein/Creatinine [Mass Ratio] in Urine | 1.8 | g/g | <=0.2 g/g | High | S |
| 2026-04-22 | Erythrocytes [#/area] in Urine sediment by Microscopy high power field | 22 | /[HPF] | <=2 /[HPF] | High | S |
| 2026-04-22 | Creatinine [Mass/volume] in Serum or Plasma | 0.8 | mg/dL | 0.5-1.1 mg/dL | Normal | S |
| 2026-04-22 | Glomerular filtration rate [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI 2021)/1.73 sq M | 101 | mL/min/{1.73_m2} | >=60 mL/min/1.73 m² | Normal | S |
Assessment
- Systemic lupus erythematosus (M32.19). ANA 1:640 meets the EULAR/ACR entry criterion, and the weighted criteria score 32 (fever, thrombocytopenia, acute cutaneous lupus, joint involvement, proteinuria, low C3 and C4, anti-dsDNA and anti-Sm), so she is classified as having lupus; anti-dsDNA 186 and anti-Sm 42 are highly specific. Disease activity is high (SLEDAI-2K 23). The arthritis of lupus mimics rheumatoid arthritis, which is why it is often misnamed. Antiphospholipid antibodies and lupus anticoagulant are negative. [S]
- Kidney involvement (R80.9). A protein-to-creatinine ratio of 1.8 g/g with dysmorphic red cells and a red cell cast and normal creatinine almost certainly means lupus nephritis. A kidney biopsy is needed now, because the class decides treatment. [S]
- Treatment. Hydroxychloroquine for every patient with lupus, at 5 mg/kg or less, now. If the biopsy shows class III or IV nephritis: three days of pulse methylprednisolone, then prednisone from about 0.5 mg/kg tapered to 5 mg a day or less by six months, with mycophenolate 2 to 3 g a day plus a second agent, either belimumab or a calcineurin inhibitor such as voclosporin, continued for years after a complete response. An angiotensin receptor blocker for proteinuria and blood pressure. If the class were V alone, the plan would change. [S]
- Vaccination and infection. Non-live vaccines are best given before immunosuppression: PCV20 and recombinant zoster can be given today and influenza was given in October. She is immune to hepatitis B by vaccination and negative for hepatitis C and HIV. Pneumocystis prophylaxis can be considered while the prednisone dose is high; sulfonamides are best avoided in lupus. [S]
- Contraception and pregnancy. Mycophenolate causes birth defects and needs highly effective contraception. With negative antiphospholipid tests, estrogen is not contraindicated by clotting risk, but an intrauterine system is the most effective choice during active disease. Pregnancy should wait for at least six months of quiet disease on compatible medicines. [S]
- Bone, avascular necrosis, and eyes. High-dose glucocorticoids threaten bone and can cause avascular necrosis of the hip, especially at high doses. A DXA at the start, vitamin D and calcium, and the lowest glucocorticoid dose protect her; new hip, groin, or knee pain needs prompt MRI. Hydroxychloroquine needs a baseline eye examination with OCT and visual fields within the first year. [S]
- Family history. Lupus clusters in families, and first-degree relatives have a much higher relative risk, although the absolute risk to any one relative is low. No genetic test is needed. She was told that treatment and outcomes today are very different from those of earlier generations. [S]
Data reviewed: Dr. Pemberton-Diallo's referral and the blood and urine tests from nine days ago; the ANA, anti-dsDNA, anti-Sm, complements, antiphospholipid antibodies, lupus anticoagulant, repeat urine protein-to-creatinine ratio, and urine microscopy drawn here this morning, which returned this afternoon; hepatitis B, hepatitis C, HIV, and pregnancy tests. [S]
Plan of Treatment
- Hydroxychloroquine 300 mg daily now, long term; baseline eye examination within the first year, then yearly from five years. [S]
- Ultrasound-guided kidney biopsy within days. [S]
- For class III or IV nephritis: methylprednisolone 500 mg daily for three days, then prednisone 30 mg tapered to 5 mg or less by six months; mycophenolate mofetil, 500 mg twice daily for a week, then 1000 mg twice daily; and belimumab or voclosporin, chosen with her. [S]
- Losartan 25 mg daily, with potassium and creatinine in two to four weeks; blood pressure below 130/80. [S]
- PCV20 and recombinant zoster dose 1 today, zoster dose 2 in one to two months, seasonal influenza and COVID-19; no live vaccines. [S]
- Levonorgestrel intrauterine system before mycophenolate, with a negative pregnancy test. [S]
- DXA at the start of glucocorticoids, vitamin D3 and dietary calcium; report hip, groin, or knee pain. [S]
- Daily sun protection; no NSAIDs; blood counts weekly for the first month on mycophenolate, then less often; urine protein, sediment, creatinine, and serology every three months. [S]
- Every result to be explained to her directly, with a written copy, and shared only with the people she names. [S]
- Discussed with Dr. Pemberton-Diallo the same day. Ms. O'Connor was told the diagnosis directly, has a written summary, and agreed to the biopsy and the plan; she will hear the biopsy result from this clinic by telephone first. [S]
- Follow-up: Kidney biopsy in two days; this clinic will give her the result and start treatment at the primary care visit in one week, then see her every three months with weekly blood counts in the first month. [S]